Risk Factors and Outcomes Associated With Posttransplant Diabetes Mellitus in Kidney Transplant Recipients

被引:37
|
作者
Siraj, E. S. [1 ,2 ]
Abacan, C. [1 ]
Chinnappa, P. [1 ]
Wojtowicz, J. [1 ]
Braun, W. [2 ,3 ]
机构
[1] Cleveland Clin, Dept Diabet Endocrinol & Metab, Cleveland, OH 44106 USA
[2] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hypertens & Nephrol, Cleveland, OH 44106 USA
关键词
INTERNATIONAL CONSENSUS GUIDELINES; RENAL-ALLOGRAFT RECIPIENTS; ISCHEMIC-HEART-DISEASE; INSULIN-RESISTANCE; CYCLOSPORINE; IMPACT; HYPERGLYCEMIA; MANAGEMENT; PROGNOSIS;
D O I
10.1016/j.transproceed.2009.12.062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although our understanding of the risk factors involved in the occurrence of posttransplant diabetes mellitus (PTDM) as well as its outcomes has improved, it still remains incomplete. Our study attempts to analyze the risk factors as well as the outcomes associated with PTDM in the renal transplant patients at the Cleveland Clinic. Methods. Our study is a retrospective, case-control study. We screened 209 charts of 217 patients who received single-organ kidney transplant at the Cleveland Clinic between January 1996 and December 1998. PTDM was defined by the American Diabetes Association criteria of either a fasting blood glucose >= 126 mg/dL or random blood sugars mg/dL confirmed on a second occasion. Kidney transplant recipients who developed PTDM (cases) were compared with kidney transplant recipients who did not develop diabetes but were matched for the time of transplant (controls). Results. Forty-nine patients (23%) developed PTDM. The data of 47 cases and 47 controls were analyzed. Age >= 40 years, body mass index >= 30, pretransplant triglyceride levels >150 mg/dL, and presence of graft rejection were significant risk factors for developing PTDM. Smoking was associated with increased risk of PTDM but failed to achieve statistical significance. Compared with controls, PTDM patients had higher risk of cardiovascular disease, infections, and graft rejection. Conclusion. Our results show that PTDM is a significant problem after kidney transplantation, and those who have high risk should be closely monitored after transplant and aggressively treated if they develop diabetes to minimize the risk of complications.
引用
收藏
页码:1685 / 1689
页数:5
相关论文
共 50 条
  • [1] Posttransplant diabetes mellitus in kidney transplant recipients
    Prokopenko, Elena
    Scherbakova, Eugenia
    Vatazin, Andrey
    Gulimova, Svetlana
    Matyuhin, Igor
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 278 - 278
  • [2] Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients
    Foo, SM
    Wong, HS
    Morad, Z
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2139 - 2140
  • [3] Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients
    Sezer, S
    Bilgic, A
    Uyar, M
    Arat, Z
    Ozdemir, FN
    Haberal, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (02) : 529 - 532
  • [4] Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients
    Andrade-Sierra, Jorge
    Contreras, Ana M.
    Monteon, Francisco J.
    Celis, Alfredo
    Gutierrez, Rodolfo
    Montanez, Jose L.
    Ruelas, Sara
    Baid-Agrawal, Seema
    Chung, Raymond T.
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (08) : 961 - 966
  • [5] Posttransplant diabetes mellitus in kidney allograft recipients: Incidence, risk factors, and management
    First, MR
    Gerber, DA
    Hariharan, S
    Kaufman, DB
    Shapiro, R
    [J]. TRANSPLANTATION, 2002, 73 (03) : 379 - 386
  • [6] Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients
    Bonato, V.
    Barni, R.
    Cataldo, D.
    Collini, A.
    Ruggieri, G.
    De Bartolomeis, C.
    Dotta, F.
    Carmellini, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (06) : 1888 - 1890
  • [7] Posttransplant diabetes mellitus in kidney transplant recipients under tacrolimus immunosuppression
    Khoury, N
    Kriaa, F
    Hiesse, C
    Von Ey, F
    Durbach, A
    Ammor, M
    Hafi, A
    Djeffal, R
    Boubenider, S
    Droupy, S
    Hammoudi, Y
    Eschwege, P
    Benoît, G
    Charpentier, B
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) : 2763 - 2764
  • [8] Incidence, Risk Factors, and Kidney Transplant Outcomes Associated with Post-Transplant Diabetes Mellitus
    Malik, R. F.
    Jia, Y.
    Mansour, S. G.
    Hall, I. E.
    Doshi, M. D.
    Reese, P. P.
    Singh, P.
    Harhay, M. N.
    Weng, F. L.
    Philbrook, H. Thiessen
    Schroppel, B.
    Muthukumar, T.
    Bromberg, J. S.
    Akalin, E.
    Mohan, S.
    Parikh, C. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1010 - 1010
  • [9] Incidence and Risk Factors of Post Transplant Diabetes Mellitus in Kidney Transplant Recipients in Qatar
    Alkadi, Mohamad
    Thappy, Shaefiq
    Abuhelaiqa, Essa
    Mahmoud, Jehan
    Jarman, Mona
    Khan, Saifat Ullah
    Makableh, Faten
    Mathew, Lilly
    Hamdi, Ahmed
    Asim, Muhammad
    Fituri, Omar
    Aziz, Adel
    Nauman, Awais
    Muthukumar, Thangamani
    Al-Malki, Hassan
    [J]. TRANSPLANTATION, 2018, 102 : S648 - S648
  • [10] Microvascular Complications of Posttransplant Diabetes Mellitus in Kidney Transplant Recipients: A Longitudinal Study
    Londero, Thiza Massaia
    Giaretta, Luana Seminotti
    Farenzena, Luisa Penso
    Manfro, Roberto Ceratti
    Canani, Luis Henrique
    Lavinsky, Daniel
    Leitao, Cristiane Bauermann
    Bauer, Andrea Carla
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (02): : 557 - 567